Section 174 Updates: Why Your R&D Tax Strategy Must Change in 2025
The most important Section 174 updates will revolutionize your R&D tax strategy in 2025. Businesses can deduct domestic research and experimental expenditures in the year they occur, starting with tax years after December 31, 2024. The One Big Beautiful Bill Act brings this fundamental change by introducing Section 174A, which permanently restores immediate deduction of domestic R&E expenditures.
These Section 174 changes provide welcome relief to businesses that don’t deal very well with the Section 174 repeal since 2022. The legislation has transition rules that let taxpayers deduct unamortized domestic R&E expenditures from 2022 through 2024. Small business taxpayers who have average annual gross receipts of $31 million or less can apply this change retroactively to taxable years after December 31, 2021. The legislation modified Section 280C and now requires domestic R&E expenditures to be reduced by the research credit amount.
This piece will help you understand how these Section 174 expenses will work going forward. You’ll learn about new options for domestic R&D tax treatment and strategic approaches to maximize your tax benefits under the new rules. We’ll cover the complex transition rules and guide you through state compliance issues that could affect your Section 174 R&D strategy.
Section 174 Repeal and the Return of Immediate Expensing
Image Source: MGO CPA
The Tax Cuts and Jobs Act (TCJA) of 2017 changed how businesses handle research and experimental expenditures. Companies could deduct all R&D costs immediately in the year incurred before this law. They also had the choice to capitalize and amortize these costs over at least 60 months. This flexibility helped companies innovate in many industries.
Impact of TCJA on Section 174 R&D Expenses
The TCJA brought new rules for tax years after December 31, 2021. Businesses had to capitalize and amortize all research expenses – domestic costs over five years and foreign costs over fifteen years. Innovation-driven industries faced major cash flow problems because of this change. The TCJA rules let taxpayers deduct only 10% of those expenses in the year they occurred. This was a big deal as it meant that ordinary business income and tax liability increased.
Section 174A Reinstatement under the OBBBA
The One Big Beautiful Bill Act (OBBBA), enacted on July 4, 2025, creates new Section 174A. This section brings back immediate expensing for domestic research costs permanently. These changes apply to costs incurred in tax years starting after December 31, 2024. Businesses can now choose to fully deduct domestic R&D expenditures in the year incurred. They can also elect to capitalize these costs and amortize them over at least 60 months.
Domestic vs Foreign R&D Treatment in 2025
The OBBBA maintains strict rules for foreign R&D activities, despite helping with domestic research. Foreign research costs must still follow the TCJA’s 15-year amortization requirement. Section 174(d) still blocks immediate recovery of the unamortized basis in foreign capitalized R&E expenditures upon disposition, retirement, or abandonment of property. Multinational organizations might move their research activities to the U.S. because of this difference. They could also work with U.S.-based contract researchers to benefit from immediate expensing.
Software development costs stay classified as R&E expenditures under both Section 174(c)(3) and the new Section 174A(d)(3). The OBBBA creates a system that needs careful tracking of domestic versus foreign R&D activities.
New Options for Domestic R&D Tax Treatment
Image Source: Corporate Tax Advisors
Businesses now have several options to handle domestic research and experimental expenditures thanks to Section 174A. These choices give companies more flexibility in tax planning and help solve the tax treatment challenges from previous TCJA requirements.
Immediate Expensing under Section 174A(a)
Section 174A(a) lets businesses deduct domestic R&E expenditures fully in the same tax year they spend the money. This 2024 tax year change gives companies the most straightforward option. Businesses can now claim their tax benefits right away instead of waiting several years. The law clearly states that “there shall be allowed as a deduction any domestic research or experimental expenditures which are paid or incurred by the taxpayer during the taxable year”.
60-Month Amortization Election under Section 174A(c)
Companies can choose to capitalize domestic R&E expenditures and amortize them over a period of not less than 60 months. They need to make this choice by their tax return due date, including any extensions. The process requires taxpayers to attach a statement to their original federal income tax return with a clear reference to Revenue Procedure 2025-28. This choice applies to current and future tax years unless the Secretary approves a method change.
10-Year Deduction Option under Section 59(e)
Section 59(e) amendments create a third option that lets taxpayers deduct domestic R&E expenditures evenly over 10 years starting when they spend the money. This option is different from Section 174A(c) because companies can make this choice yearly instead of permanently. Companies get more room to adjust their tax planning strategies each year.
Software Development Costs under Section 174A(d)(3)
Section 174A(d)(3) makes it clear that “any amount paid or incurred in connection with the development of any software shall be treated as a research or experimental expenditure”. This follows the same approach that’s been in place since TCJA Section 174(c)(3). Tech companies can now use all three options for their software development costs, giving them plenty of ways to manage their tax positions.
Transition Rules and Retroactive Deduction Strategies
Image Source: Fincent
Businesses can recover their previously capitalized R&D costs through several pathways. The shift from TCJA’s capitalization requirement to Section 174A’s immediate expensing makes this possible. Tax benefits can be maximized by learning about these options as we adapt to these most important section 174 changes.
One-Year vs Two-Year Catch-up Deduction for 2022–2024
Businesses will have options to handle unamortized domestic R&D costs from 2022-2024 starting in 2025. OBBBA Section 70302(f)(2)(A) lets you choose between two paths: you can deduct 100% of remaining unamortized domestic R&E expenditures in 2025, or split the deduction between 2025 and 2026. Your 2025 tax return must include this election. Your projected income for both years should guide your choice. Higher marginal tax rates usually make deductions more valuable.
Section 481(a) Adjustment and Form 3115 Filing
A Section 481(a) adjustment prevents duplicate or missing income and deductions during accounting method changes. The section 174 r&d transition needs a modified Section 481(a) adjustment if methods change after the first applicable tax year. This adjustment only includes R&E expenses paid after December 31, 2021. Your Form 3115 (Application for Change in Accounting Method) needs details about expenditure types, tax years, and an explanation of the accounting change.
Modified Cut-off Method for Short Tax Years
A modified cut-off approach with a Section 481(a) adjustment applies to businesses with short tax years that start after December 31, 2024, and end before July 4, 2025. This adjustment only counts unamortized domestic R&E expenditures paid in that short tax year.
Small Business Retroactive Election under Section 448(c)
The most beneficial section 174 tax provision helps “eligible small businesses.” These are companies with average annual gross receipts under $31 million in the three years before 2025. Such businesses can apply Section 174A to 2022-2024 through amended returns or an accounting method change. July 6, 2026, is the deadline to make this election. Small businesses that file their 2024 return before September 15, 2025, without an extension get six extra months to file a superseding return.
Strategic Planning for Section 280C and State Compliance
Image Source: MGO CPA
The section 174 updates bring more than just immediate benefits. Taxpayers need to understand complex tax credit interactions and state tax rules. This understanding helps create better tax planning strategies for 2025 and beyond.
Interaction Between Section 174A and R&D Tax Credit
The research credit qualification now depends on Section 41(d). It requires expenditures to qualify as domestic R&E expenditures under Section 174A. Your section 174 r&d strategy directly connects to credit eligibility. Businesses should coordinate their Section 174A elections with research credit planning to get the best tax benefits.
Section 280C(c) Election: Reduced Credit vs Reduced Deduction
The OBBBA passage requires taxpayers to reduce their Section 174A deduction by their research credit amount under Section 280C(c)(1). Businesses can choose to claim a reduced research credit instead, according to Section 280C(c)(2). This choice needs a timely filed return that includes extensions. Small businesses can make a late Section 280C(c)(2) election for specific TCJA 174 years if they filed the original return before September 15, 2025.
State Conformity Challenges with Section 174A
Tax changes affect states differently. 26 states automatically follow federal updates through “rolling conformity”. Another 19 states use “static conformity” tied to specific dates. California, Mississippi, Tennessee, Texas, and Wisconsin have separated from TCJA Section 174 rules. States like Maryland use “circuit breaker” provisions to block expensive federal tax changes. This varied landscape requires careful planning across multiple jurisdictions.
Partnership-Level Impacts and BBA AAR Requirements
Partnerships under the Bipartisan Budget Act centralized audit regime should file Administrative Adjustment Requests (AARs) for small business OBBBA elections. The adjustments affect reviewed-year partners and show tax effects in the AAR filing year (2025 or 2026). The timing of AAR filing could significantly change partner-level benefits.
Conclusion
The One Big Beautiful Bill Act for 2025 brings the most important changes to Section 174 that will affect research-intensive businesses of all sizes across America. After years of mandatory capitalization, companies must now make crucial decisions about their R&D expenses. Domestic research can return to immediate expensing, which brings welcome relief. Foreign R&D activities still need 15-year amortization.
Tax planning has become crucial as businesses review which approach serves their financial goals best. Your company could benefit from the simple immediate expensing option under Section 174A(a) or find better advantages through other amortization paths. On top of that, small businesses can get substantial benefits from the new rules’ retroactive applications.
The transition period needs your attention now. Your company must choose between taking unamortized 2022-2024 domestic R&E expenditures as one deduction or spreading them over two years. This choice should line up with your projected income levels and overall tax strategy. You’ll need to prepare Form 3115 filings carefully to meet Section 481(a) adjustment requirements.
State tax issues have altered the map since many states haven’t decided how to match these federal changes. Companies operating in multiple jurisdictions should get ready for different state-level treatments of R&D expenses.
We suggest working with qualified tax professionals to create a complete strategy that maximizes your benefits under these new Section 174 rules. Time is running out to make these crucial elections, especially for small businesses that want retroactive treatment. The plans you make today will determine how well your organization uses these tax law changes throughout 2025 and beyond.
Key Takeaways
The Section 174 updates for 2025 bring significant changes that require immediate strategic planning for R&D-intensive businesses to maximize tax benefits and ensure compliance.
• Immediate expensing returns for domestic R&D: Starting in 2025, businesses can again deduct domestic research expenses in the year incurred under new Section 174A, while foreign R&D remains subject to 15-year amortization.
• Multiple deduction options provide flexibility: Companies can choose immediate expensing, 60-month amortization, or 10-year deduction under Section 59(e), allowing customized tax planning based on income projections.
• Transition rules offer catch-up opportunities: Businesses can deduct unamortized 2022-2024 domestic R&D costs either entirely in 2025 or spread across 2025-2026, requiring strategic timing decisions.
• Small businesses gain retroactive benefits: Companies with under $31 million average annual gross receipts can retroactively apply Section 174A to 2022-2024 through amended returns or accounting method changes.
• State compliance creates complexity: With 26 states following federal changes automatically and 19 using static conformity, multi-jurisdictional businesses must prepare for inconsistent state-level R&D expense treatment.
The window for making critical elections is narrow, particularly for small businesses seeking retroactive treatment. Proactive planning with qualified tax professionals is essential to capture the full advantage of these transformative changes and coordinate R&D deductions with research credit strategies under modified Section 280C rules.
FAQs
Q1. What are the key changes to Section 174 for R&D expenses in 2025? Starting in 2025, businesses can once again deduct domestic research and experimental expenditures in the year they are incurred. This change comes through the One Big Beautiful Bill Act, which introduces Section 174A to permanently restore immediate deduction of domestic R&E expenditures.
Q2. How will foreign R&D expenses be treated under the new rules? Despite the changes for domestic research, foreign R&D activities remain subject to stricter treatment. Foreign research costs will still be subject to the 15-year amortization requirement established by the Tax Cuts and Jobs Act of 2017.
Q3. What options do businesses have for handling domestic R&D expenses under the new Section 174A? Businesses have three main options: 1) Immediate expensing under Section 174A(a), 2) 60-month amortization election under Section 174A(c), or 3) 10-year deduction option under Section 59(e). Each option offers different tax planning opportunities based on a company’s specific circumstances.
Q4. Are there any special provisions for small businesses regarding Section 174 changes? Yes, eligible small businesses with average annual gross receipts under $31 million for the three-year period preceding 2025 can retroactively apply Section 174A to 2022-2024. This can be done through either amended returns or an accounting method change, providing significant potential benefits.
Q5. How do the Section 174 changes impact state-level taxes? The impact on state-level taxes varies widely. Currently, 26 states automatically follow federal tax changes, while 19 states use “static conformity” tied to specific dates. Some states have already decoupled from the federal rules, creating a complex landscape for businesses operating across multiple jurisdictions.
